Jane Street
FLGT icon

Jane Street’s Fulgent Genetics FLGT Stock Holding History

Jane Street’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-8,500
Closed -$253K – 9282
2022
Q4 		$253K Sell
8,500
-15,600
-65% -$558K ﹤0.01% 7302
2022
Q3 		$919K Sell
24,100
-210,900
-90% -$10.6M ﹤0.01% 5555
2022
Q2 		$12.8M Buy
235,000
+98,400
+72% +$5.41M 0.01% 1484
2022
Q1 		$8.53M Buy
136,600
+44,500
+48% +$2.93M ﹤0.01% 2198
2021
Q4 		$9.26M Buy
92,100
+29,700
+48% +$2.61M ﹤0.01% 1971
2021
Q3 		$5.61M Sell
62,400
-89,200
-59% -$8.11M ﹤0.01% 2555
2021
Q2 		$14M Sell
151,600
-52,100
-26% -$4.16M 0.01% 1381
2021
Q1 		$19.7M Buy
203,700
+95,500
+88% +$9.86M 0.01% 986
2020
Q4 		$5.64M Buy
108,200
+100,200
+1,253% +$4.19M ﹤0.01% 1990
2020
Q3 		$320K Buy
+8,000
New +$250K ﹤0.01% 5791

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Jane Street's FLGT Position: Q1 2026 in Review

Jane Street sold out of Fulgent Genetics (FLGT) in Q1 2026, closing a stake of 149,988 shares — an estimated $3.94M sold.

Jane Street first reported a position in FLGT in Q1 2020 and held it in 23 quarters. The position peaked at $6.15M in Q4 2021. 157 funds tracked by Wall St. Rank hold FLGT as of Q1 2026.

  • Jane Street reported no remaining Fulgent Genetics position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 149,988 Fulgent Genetics shares in Q1 2026, an estimated $3.94M.
  • Jane Street first reported a position in Fulgent Genetics in Q1 2020 and held it in 23 quarters.
  • Jane Street's Fulgent Genetics position peaked at $6.15M in Q4 2021.
  • 157 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.